Stonebridge Financial Planning Group, LLC Abb Vie Inc. Transaction History

Stonebridge Financial Planning Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $19,797 - $24,562	-150 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $5,260 - $5,860	-50 Reduced 25.0%	150 $18,000
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $2,557 - $2,815	-25 Reduced 11.11%	200 $22,000
Q1 2020 Apr 15, 2020	BUY	$64.5 - $97.79 $4,837 - $7,334	75 Added 50.0%	225 $18,000
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $10,819 - $13,537	150 New	150 $13,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Stonebridge Financial Planning Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Financial Planning Group, LLC with notifications on news.